ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EXAI Exscientia PLC

4.73
-0.46 (-8.86%)
After Hours
Last Updated: 00:35:00
Delayed by 15 minutes
Name Symbol Market Type
Exscientia PLC NASDAQ:EXAI NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.46 -8.86% 4.73 4.68 4.89 5.15 4.6101 5.15 784,944 00:35:00

Exscientia to Present at Upcoming Investor Conferences in March

28/02/2024 12:00pm

Business Wire


Exscientia (NASDAQ:EXAI)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Exscientia Charts.

Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March:

  • TD Cowen 44th Annual Health Care Conference. Fireside chat on Wednesday, March 6, 2024 at 2:10 p.m. EST (7:10 p.m. GMT) in Boston, Massachusetts
  • Barclays 26th Annual Global Healthcare Conference. Fireside chat on Tuesday, March 12, 2024 at 1:05 p.m. EDT (5:05 p.m. GMT) in Miami, Florida
  • KeyBanc Capital Markets Life Sciences & MedTech Investor Forum. Fireside chat on Tuesday, March 19, 2024 at 2:15 p.m. EDT (6:15 p.m. GMT), virtual

Live webcasts of the presentations will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients. For more information visit us on www.exscientia.ai or follow us on LinkedIn @ex-scientia and X @exscientiaAI.

Investor Relations Contact: Sara Sherman / Chinedu Okeke investors@exscientia.ai Media Contact: Oliver Stohlmann media@exscientia.ai

1 Year Exscientia Chart

1 Year Exscientia Chart

1 Month Exscientia Chart

1 Month Exscientia Chart

Your Recent History

Delayed Upgrade Clock